Divergent and Convergent TMEM106B Pathology in Murine Models of Neurodegeneration and Human Disease.
Ontology highlight
ABSTRACT: TMEM106B is a lysosomal/late endosome protein that is a potent genetic modifier of multiple neurodegenerative diseases as well as general aging. Recently, TMEM106B was shown to form insoluble aggregates in postmortem human brain tissue, drawing attention to TMEM106B pathology and the potential role of TMEM106B aggregation in disease. In the context of neurodegenerative diseases, TMEM106B has been studied in vivo using animal models of neurodegeneration, but these studies rely on overexpression or knockdown approaches. To date, endogenous TMEM106B pathology and its relationship to known canonical pathology in animal models has not been reported. Here, we analyze histological patterns of TMEM106B in murine models of C9ORF72-related amyotrophic lateral sclerosis and frontotempor
SUBMITTER: Du M
PROVIDER: S-EPMC11601866 | biostudies-literature | 2024 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA